CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
argenx SE - ADR Company Snapshot
argenx SE operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other companies in this sector in UNITED STATES : Zymeworks Inc (2020 sales of $38.95 million of which 100% was tion), Deciphera Pharmaceuticals Inc ($42.09 million of which 100% was pharmaceutical, biotechnology), and Revolution Medicines Inc ($42.98 million of which 100% was BIOLOGICAL PRODUCTS).

Sales Analysis. argenx SE reported sales of $41.79 million for the year ending December of 2020. This represents a sharp decrease of 46.4% versus 2019, when the company's sales were $78.00 million.
   
   
 
  Stock Performance Chart for argenx SE - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (2/26/2021): 330.68
(Figures in U.S. Dollars)
1 Week -10.7%   13 Weeks 12.9%  
4 Weeks 17.4%   52 Weeks 133.9%  
 
argenx SE - ADR Key Data:
  Ticker: ARGX Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 41,788,581
(Year Ending Jan 2021).
Employees: 188
  Currency: U.S. Dollars Market Cap: 15,730,871,862
  Fiscal Yr Ends: December Shares Outstanding: 47,571,283
  Share Type: ADR Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.